newsfilter
← Latest News
PR Newswire·

Ampio Provides Update on Results from Pre-IND Enabling Studies

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development of ...